We are pleased to announce that our company will be invited to participate in the
2026 Taiwan–U.S. Health Industry Investment Seminar, jointly organized by the American Institute in Taiwan (AIT) and the Biotech and Pharmaceutical Industry Promotion Office (BPIPO) of Taiwan’s Ministry of Economic Affairs. The seminar will be held on January 29, 2026, in Taipei.
The event focuses on investment opportunities and market entry strategies for Taiwan’s health technology and biotech industries in the United States, bringing together U.S. state representatives, regulatory and tax experts, and executives with firsthand experience in U.S. expansion.
Our company is expected to take part in the seminar discussions, sharing insights from our work in the health technology sector and engaging with international partners to explore future collaboration and global growth opportunities.
We look forward to leveraging this opportunity to strengthen our international presence and contribute to cross-border innovation within the global health ecosystem.
Info:
January 29, 09:00-12:00
Grand Hyatt Taipei, No. 2, Songshou Road, Xinyi District, Taipei
Registration here [link to registration]
